HBeAg seroconversion and HBsAg loss among anti-retroviral therapy (HAART) in patients with HBV-HIV co-infection

Kosi Lana; Reiberger Thomas; Rutter KarolinePfistershammer ArminRieger ArminPeck-Radosavljevic Markus

首页> 外文期刊>wiener klinische wochenschrift >HBeAg seroconversion and HBsAg loss among anti-retroviral therapy (HAART) in patients with HBV-HIV co-infection

【24h】

HBeAg seroconversion and HBsAg loss among anti-retroviral therapy (HAART) in patients with HBV-HIV co-infection

机译：HBV-HIV合并感染患者抗逆转录病毒治疗（HAART）中的HBeAg血清转化和HBsAg缺失

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《wiener klinische wochenschrift》 |2009年第16期|A22-A22|共1页
作者
Kosi Lana; Reiberger Thomas; Rutter KarolinePfistershammer ArminRieger ArminPeck-Radosavljevic Markus;
展开▼
作者单位

Med Univ Wien, Gastroenterol & Hepatol Abt, Vienna, Austria;

Med Univ Wien, Abt Dermatol, Abt Immundermatol & Infektiose Hautkrankheiten, Vienna, Austria;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词

相似文献

外文文献
中文文献

1. Viral hepatitis B and C co-infection with Human Immunodeficiency Virus among adult patients attending selected highly active anti-retroviral therapy clinics in Nigeria's capital [J] . Nneoma Confidence Jeanstephanie Anyanwu, Peace Temitope Sunmonu, Miracle Hyimi Mathew Journal of immunoassay and immunochemistry . 2020,第3期

机译：Viral hepatitis B and C co-infection with Human Immunodeficiency Virus among adult patients attending selected highly active anti-retroviral therapy clinics in Nigeria's capital
2. Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96?weeks is associated with low baseline HBsAg levels [J] . Samuel A. L. Hall, Gareth S. Burns, Despina AnagnostouSara VogrinVijaya SundararajanDilip RatnamMiriam T. LevyJohn S. LubelAmanda?J. NicollSimone I. StrasserWilliam SievertPaul V. DesmondMeng C. NguPeter AngusMarie SinclairChristopher MeredithGail MatthewsPeter A. RevillKathy JacksonMargaret LittlejohnD.?Scott BowdenStephen A. LocarniniKumar VisvanathanAlexander?J. Thompson Alimentary pharmacology & therapeutics. . 2022,第2期

机译：Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96?weeks is associated with low baseline HBsAg levels
3. Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naive patients [J] . Li Jing, Qu Lihong, Sun XuehuaLiu YanhongGong QimingYu DeminZhang DonghuaJiang JiehongChen JiaWei DongHan YueGao YueqiuZhang QinShe WeiminChen LiangZhang JimingZhang Xinxin Journal of viral hepatitis. . 2021,第10期

机译：Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naive patients
4. Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals [O] . Gail V. Matthews, Rachel J. Ali, Anchalee Avihingsanon, -1

机译：HBsAg和HBeAg的定量预测在感染HIV-HBV的个体中启动HAART后的乙型肝炎血清转化
5. Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: Results of a 2-year follow-up study [O] . Izumi, Kouji 　, Mizokami, Atsushi, Sugimoto, Kazuhiro, 2011

机译：Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: Results of a 2-year follow-up study

HBeAg seroconversion and HBsAg loss among anti-retroviral therapy (HAART) in patients with HBV-HIV co-infection

著录项

引文网络

相似文献

相关主题

期刊订阅